TP53 and neoplasm: These acid‐adapted organoids were used to investigate how tumor acidosis confers chemoresistance. It was demonstrated that acid adaptation enhances viability and increases the expression of gemcitabine resistance genes, particularly in p53 wild‐type organoids.